Bentham Science Logo

Track Your Manuscript:


Current Signal Transduction Therapy

Volume 15, 3 Issues, 2020
ISSN: 2212-389X (Online)
ISSN: 1574-3624 (Print)
This journal supports open access

Contents

Current Signal Transduction Therapy, Volume 6 - Number 1







Multiplex Analysis of Cardiac Hypertrophic Signaling: Reduced in vivo Phosphorylation of Glycogen Synthase Kinase-3β and Proline-Rich Akt Substrate (PRAS40)

, 6(1): 65 - 70

Jens R. Larsen, Morten Smerup, Rikke Norregaard, Jane H. Christensen, Kim Sivesgaard, Sara D. Christensen, Karin Christensen, Erik Sloth, Peter Torp, Niels Gregersen and J. Michael Hasenkam


DOI: 10.2174/157436211794109406




Serine-Threonine Protein Kinases CK1, CK2 and GSK3 in Normal and Malignant Haematopoiesis

, 6(1): 88 - 98

Francesco Piazza, Sabrina Manni, Anna Colpo, Laura Quotti Tubi, Carmela Gurrieri and Gianpietro Semenzato


DOI: 10.2174/157436211794109370






Editor-in-Chief

Jingxuan Yang
The University of Oklahoma Health Science Center
Oklahoma City, OK
(USA)

Biography
View Full Editorial Board

COPE Compliant

Journal History

Current Signal Transduction Therapy was launched in 2006. Dr. Jingxuan Yang serves as the Editor-in-Chief of the journal.

Advertisement

How to write and publish your papers in high impact journalsCovid Resource Center

Related Journals

Related eBooks

eBooks Catalog